Axsome Therapeutics Inc
F:19X
Axsome Therapeutics Inc
F:19X
Price:
197.85
EUR
2.09%
Market Closed
Market Cap:
€9.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Axsome Therapeutics Inc
F:19X
|
US |
|
E
|
Endeavour Silver Corp
SWB:EJD
|
CA |
|
F
|
Fortinet Inc
XBER:FO8
|
US |
|
V
|
Viscofan SA
DUS:VIS
|
ES |
|
A
|
Anglo American PLC
SIX:AAM
|
UK |
|
Phenom Resources Corp
F:1PY0
|
CA |
|
P
|
PNC Financial Services Group Inc
XMUN:PNP
|
US |
Wall St Price Targets
19X Price Targets Summary
Axsome Therapeutics Inc
Axsome Therapeutics Inc
Wall Street analysts forecast 19X stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 19X is 131.36 EUR with a low forecast of 115.46 EUR and a high forecast of 156.05 EUR.
Lowest Forecast
Price Target
115.46
EUR
42% Downside
Average Forecast
Price Target
131.36
EUR
34% Downside
Highest Forecast
Price Target
156.05
EUR
21% Downside
Axsome Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 19X's stock price target?
Price Target
131.36
EUR
131.36
EUR
According to Wall Street analysts, the average 1-year price target for 19X is 131.36 EUR with a low forecast of 115.46 EUR and a high forecast of 156.05 EUR.
What is the Revenue forecast for Axsome Therapeutics Inc?
Projected CAGR
27%
27%
The compound annual growth rate for Revenue over the next 8 years is 27%.
